Part of the shareholders of Novoprotein Scientific Inc. (688137.SH) intend to collectively reduce their holdings by no more than 1.04% of the shares.

Novoprotein Scientific Inc. (688137.SH) announced that its shareholders, Nanjing Jinli Entrepreneurship Investment Partnership Enterprise (Limited Partnership) (referred to as "Nanjing Jinli") and Suzhou Jinling Entrepreneurship Investment Partnership Enterprise (Limited Partnership) (referred to as "Suzhou Jinling"), plan to collectively reduce their holdings of the company's shares by no more than 728,600 shares, accounting for 1.04% of the company's total share capital.